Posted by Michael Wonder on 02 Jul 2019
Drug price TV ad rule will cause consumer confusion, drug makers argue
2 July 2019 - Three drug makers on Monday urged a federal judge to block a new Trump administration rule that requires them to disclose drugs’ list prices in television advertisements from taking effect, saying it would “confuse and intimidate” consumers.
Merck, Eli Lilly and Amgen in a brief filed in federal court in Washington, D.C. argued the U.S. Department of Health and Human Services’ rule would force them to disclose a price most patients with insurance never pay.
